1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zebrafish models of cancer: Progress and future challenges
    Journal Article

    Yen, J.; White, R. M.; Stemple, D. L.
    Current Opinion in Genetics and Development (2014)

    Fulltext@MSK | Save
  • Emerging therapies for pancreas neuroendocrine cancers
    Review

    Mahjoub, A. R.; O'Reilly, E. M.
    Chinese Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Adenocarcinoma of the colon and rectum
    Book Section

    Weiser, M. R.; Posner, M. C.; Saltz, L. B.; Yeo, C. J.
    In Yeo, C. J. (Eds.) Shackelford's Surgery of the Alimentary Tract. 7th ed (2013)

    Fulltext@MSK | Save
  • Characterization of rectal cancer in patients with Lynch syndrome
    Meeting Abstract

    Stadler, Z. K.; Shia, J.; Goodman, K. A.; Cercek, A.; Segal, N. H.; Reidy, D. L.; Yaeger, R. D.; Nash, G. M.; Temple, L. K. F.; Kemeny, N. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma
    Meeting Abstract

    Won, E.; Ilson, D.; Kelsen, D. P.; Strong, V. E.; Schoder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Identification of germline genetic mutations in patients with pancreatic adenocarcinoma
    Meeting Abstract

    Salo-Mullen, E. E.; O'Reilly, E. M.; Kelsen, D. P.; Lowery, M. A.; Yu, K. H.; Rau-Murthy, R.; Siegel, B.; Saltz, L.; Kurtz, R. C.; Offit, K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Use of pharmacogenomic modeling in pancreatic cancer for prediction of chemotherapy response and resistance
    Meeting Abstract

    Sangar, V.; Ricigliano, M.; O'Reilly, E. M.; Abou-Alfa, G. K.; Lowery, M. A.; Saltz, L.; Crotty, J. F.; Gary, K.; Choi, E. Y.; Yin, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y. M.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Janjigian, Y. Y.; Shah, M. A.; Herrera, J.; Tang, L. H.; Fuqua, L.; Capanu, M.; Ilson, D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A randomized phase II study of vismodegib (V), a hedgehog (HH) pathway inhibitor, combined with FOLFOX in patients (pts) with advanced gastric and gastroesophageal junction (GEJ) carcinoma: A New York Cancer Consortium led study
    Meeting Abstract

    Cohen, D. J.; Christos, P. J.; Sparano, J. A.; Kindler, H. L.; Catenacci, D. V. T.; Bekaii-Saab, T. B.; Tahiri, S.; Janjigian, Y. Y.; Gibson, M. K.; Chan, E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save